No profile data available.
Annexon, Inc. (ANNX) is a healthcare company in the brain and nerve treatment drugs industry, based in Brisbane, United States, with about 92 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$206.69 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $762.11 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.
Annexon reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$762.11 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include LB Pharmaceuticals Inc (LBRX), Capricor Therapeutics, Inc. (CAPR), Alto Neuroscience, Inc. (ANRO), Solid Biosciences Inc. (SLDB).